|
Contents
|
|
|
|
Embryonal
Tumors |
|
|
|
Bevacizumab,
Celecoxib, Cyclophosphamide, Etoposide, Fenofibrate, Thalidomide
|
Peyrl
A, Chocholous M, Kieran MW, Azizi AA, Prucker C, Czech T, Dieckmann K,
Schmook MT, Haberler C, Leiss U, Slavc I.
Antiangiogenic metronomic therapy for children with recurrent embryonal
brain tumors.
Pediatr Blood Cancer. 2011 Dec 6;. [Epub ahead of print]
.JPG) Abstract |
.gif) Related articles
|
|
|
Germ
Cell Tumors
|
|
|
|
Kellie SJ,
Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary
chemotherapy for intracranial nongerminomatous germ cell tumors: results of the
second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53.
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
Mee Jeong Lee, Young Shin Ra,
Jun Bum Park, Hyun Woo Goo, Seung Do Ahn,
Shin Kwang Khang, Joon Sup Song, Yoon Jung Kim
and Thad T. Ghim
Effectiveness
of novel combination chemotherapy, consisting of 5-fluorouracil,
vincristine, cyclophosphamide and etoposide, in the treatment of low-grade
gliomas in children
.png) Journal of
Neuro-Oncology, Volume 80, Number 3 / December, 2006, Pages 277-284,
Published online: 29 June 2006
|
|
|
Malignant
Lymphoma
|
|
|
|
Brian
Patrick O'Neill, Judith Rich O'Fallon, Stephen S Cha, Paul J Kurtin, Bernd W
Scheithauer, Paul D Brown, Thomas A Habermann, Fernando K Addo, Mark Gilbert
Newly
diagnosed primary central nervous system lymphoma (PCNSL): initial report of
North Central Cancer Treatment Group (NCCTG)/Eastern Cooperative Oncology Group
(ECOG) protocol 93 73 51
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 2074
|
|
|
Medulloblastoma
|
|
|
|
Alba A Brandes, Mario Ermani, Pietro
Amista, Umberto Basso, Francesca Vastola, Antonino Rotilio, Carlo Mazza, Franco
Ammannati, Bianca Guglielmi, Franco Berti
A
prospective study on medulloblastoma (MB) in adults
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
301
|
|
Amar Gajjar
MD, Murali Chintagumpala MD,
David Ashley MBBS, Stewart Kellie
MBBS, Prof Larry E Kun MD, Prof
Thomas E Merchant DO, Shaio Woo
MD, Greg Wheeler MBBS, Valerie Ahern
MBBS, Matthew J Krasin MD, Maryam Fouladi
MD, Alberto Broniscer MD, Prof
Robert Krance MD, Gregory A Hale
MD, Clinton F Stewart PharmD,
Robert Dauser MD, Prof
Robert A Sanford MD, Christine Fuller
MD, Ching Lau MD, Prof
James M Boyett PhD, Dana Wallace
MS and Richard J Gilbertson MD
Risk-adapted
craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell
rescue in children with newly diagnosed medulloblastoma (St Jude
Medulloblastoma-96): long-term results from a prospective, multicentre
trial
Lancet Oncology Early
Online Publication, 7 September 2006,
DOI:10.1016/S1470-2045(06)70867-1
Abstract
/ BrainLife
|
.gif)
News
News
|
|
|
Kadota RP, Mahoney DH, Doyle J, Duerst R,
Friedman H, Holmes E, Kun L, Zhou T, Pollack IF.
Dose intensive melphalan and cyclophosphamide with autologous
hematopoietic stem cells for recurrent medulloblastoma or germinoma
Pediatr Blood Cancer. 2008 Jul 11; [Epub ahead of print]
Abstract
|
|
|
Metastatic
Tumors
|
|
|
|
Colleoni M, Rocca A, Sandri MT,
Zorzino L, Masci G, Nole F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de
BF, Viale G, Goldhirsch A
Low-dose
oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor
activity and correlation with vascular endothelial growth factor levels
Ann
Oncol 2002 Jan;13(1):73-80
|
|
|
Hong
JJ, Rosenberg SA, Dudley ME, Yang JC, White DE, Butman JA, Sherry RM
Successful
Treatment of Melanoma Brain Metastases With Adoptive Cell Therapy
Clin
Cancer Res. 2010 Aug 23. [Epub ahead of print]
Abstract
|
|
Laura Orlando, Anna Cardillo, Raffaella Ghisini,
Andrea Rocca, Alessandra Balduzzi, Rosalba Torrisi, Giulia Peruzzotti, Aron
Goldhirsch, Elisabetta Pietri, and Marco Colleoni
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate
in patients with HER-2 positive metastatic breast cancer
BMC Cancer. 2006 Sep
15;6:225
Abstract
| .png)
Full
Text |
Reprint
|
|
|
Neuroblastoma
|
|
|
|
A. Donfrancesco, A. Jenkner, A.
Castellano, I. Ilari, G. M. Milano, C. Dominici, L. De Sio, P. Fidani
Front-line topotecan and
high-dose cyclophosphamide followed by ICE in high-risk neuroblastoma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8536
|
|
C. N. Frantz, W. B. London, L.
Diller, R. Seeger, K. Sawyer
Recurrent neuroblastoma: Randomized
treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A
POG/CCG Intergroup Study
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8512
|
|
H
Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles, C Bergeron, C
Thomas, P Chastagner, D Valteau-Couanet, J Michon, V Mosseri and O Hartmann
Localised
and unresectable neuroblastoma in infants: excellent outcome with low-dose
primary chemotherapy
British
Journal of Cancer3
November 2003, Volume 89, Number 9,
1605-1609
|
|
|
Non-Nervous System
T.
|
|
|
|
Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly
MS, Folkman J
Antiangiogenic
scheduling of chemotherapy improves efficacy against experimental drug-resistant
cancer
Cancer Res 2000 Apr 1;60(7):1878-86 (PDF Full Text)
|
|
Man
S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ,
Bergers G, Kerbel RS
Antitumor
effects in mice of low-dose (metronomic) cyclophosphamide administered
continuously through the drinking water
Cancer
Res 2002 May 15;62(10):2731-5
|
|
|
Paraneoplastic Neur. Dis.
|
|
|
|
Steven Vernino,
Brian Patrick O’Neill, Randolph S. Marks, Judith R. O’Fallon, and David W.
Kimmel
Immunomodulatory
treatment trial for paraneoplastic neurological disorders
Neuro-Oncology, January 2004, Volume 6, Number 1, Pages: 55 -- 62 (Abstract+)
|
|
